Hepatitis C Virus
Hepatitis C virus protease functions in evasion of innate immunity
Published in Hepatitis Weekly, February 6th, 2006
"HCV is a global epidemic manifested mainly by chronic infection. One strategy that HCV employs to establish chronic infection is to use the viral Ser protease NS3/4A to cleave some unknown cellular targets involved in innate immunity."
"Here we show that the target of NS3/4A is the mitochondrial antiviral signaling protein, MAVS, that activates NF-kappa B and IFN regulatory factor 3 to induce type-1 interferons," wrote X.D. Li and colleagues, University of Texas,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-02-06)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Foscarnet reduces hepatitis B virus DNA replication - Hepatitis B Virus
Naive antibody phage library contains HBV neutralizing antibody fragments - Hepatitis B Virus
Pre-emptive lamivudine treatment is warranted in heart transplant patients with chronic hepatitis B - Hepatitis C Virus
High mortality rate is associated with HCV cirrhosis in liver retransplantation - Alcoholism
New automated method measures total antioxidant response in nonalcoholic steatohepatitis - Antibacterial Agents
Retroscreen study shows chlorhexidine hand sanitizer over 99% effective on bird flu virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
